CG
MBOT icon

Cutler Group’s Microbot Medical MBOT Stock Holding History

Cutler Group’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,700
Closed -$6K – 4110
2023
Q2 		$6K Buy
+16,700
New +$33.4K ﹤0.01% 2543

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's MBOT Position: Q4 2023 in Review

Cutler Group sold out of Microbot Medical (MBOT) in Q4 2023, closing a stake of 100 shares — an estimated $133 sold.

Cutler Group first reported a position in MBOT in Q3 2023 and held it in 1 quarter. The position peaked at $0 in Q3 2023. 36 funds tracked by Wall St. Rank hold MBOT as of Q4 2023.

  • Cutler Group reported no remaining Microbot Medical position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 100 Microbot Medical shares in Q4 2023, an estimated $133.
  • Cutler Group first reported a position in Microbot Medical in Q3 2023 and held it in 1 quarter.
  • Cutler Group's Microbot Medical position peaked at $0 in Q3 2023.
  • 36 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.